ABSTRACT
Coronary artery disease (CAD) and heart failure (HF) are the leading causes of morbidity and mortality among patients with diabetes mellitus. Patients with diabetes are more likely to have more severe CAD (including three vessel diseases), they are more likely to experience episodes of silent ischemia, the outcome of which is worse than that of non-diabetic patients with coronary artery disease. This chapter focuses on therapeutic options for stable coronary artery disease, acute coronary syndromes, and heart failure.
